HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cortical silent period and motor evoked potentials in patients with multiple sclerosis.

Abstract
In order to determine the importance of central motor conduction time (CMCT) and silent period (SP) in patients with multiple sclerosis (MS), we enrolled this clinical and electrophysiological study. Additionally, we planned to compare the correlation between electrophysiological findings and clinical status. We examined 58 patients with definite MS and 31 controls. Patients were classified as relapsing-remitting (N: 37), secondary progressive (N: 21) groups. Eleven out of 58 patients with MS had no neurological findings (subclinical patients). We evaluated CMCT and the duration of SP. Prolonged CMCT latency was shown in 75.2% of patients. We observed SP abnormalities in 69% of patients. In subclinical patients, SP abnormalities (six of 11) were observed more common than CMCT (two of 11). The duration of SP was extremely prolonged in MS patients with cerebellar dysfunction. When the both electrophysiological parameters are taken into account, the abnormality ratio was determined as 89.7%. Our results indicate that CMCT and SP analysis are complementary tests in evaluating motor pathways of patients with MS. We observed a relationship between cerebellar dysfunction and SP prolongation. It is suggested that, SP can be applied in patients with pure cerebellar dysfunction and it can be a valuable test in subclinical cases with MS.
AuthorsCengiz Tataroglu, Ahmet Genc, Egemen Idiman, Raif Cakmur, Fethi Idiman
JournalClinical neurology and neurosurgery (Clin Neurol Neurosurg) Vol. 105 Issue 2 Pg. 105-10 (Apr 2003) ISSN: 0303-8467 [Print] Netherlands
PMID12691802 (Publication Type: Journal Article)
Topics
  • Adolescent
  • Adult
  • Cerebellum (pathology)
  • Disease Progression
  • Electroencephalography
  • Evoked Potentials, Motor
  • Female
  • Humans
  • Male
  • Middle Aged
  • Multiple Sclerosis (physiopathology)
  • Neural Conduction
  • Severity of Illness Index

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: